Company / Interest Expense per Share
Stoke Therapeutics, Inc. Interest Expense per Share History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.00
FY2025
5-year range
$0.00 / $0.00
FY2024-FY2025
Trend
-84.4%
vs FY2024
Sector context
#38 of 43
Health Care
What the data says
Stoke Therapeutics, Inc.'s interest expense per share of $0.00 is lower than 88% of companies in the Health Care sector (FY2025).
Based on SEC 10-K filings.
0.00 in FY2025.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 43This company $0.00 Sector average $18.61
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, interest expense per share decreased 84.4% year-over-year.
- Ranks #38 out of 43 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | -84.4% |
| FY2024 | $0.00 | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026